The Supreme Court on Thursday kept current nationwide access to the abortion medication mifepristone in place, blocking lower court limits that would have required in-person doctor visits and halted distribution through the mail while the case moves forward. Louisiana initially filed a lawsuit seeking to roll back Food and Drug... Read More »